Skip to content

Rehabilitation of Adolescents Living With Chronic Fatigue

Rehabilitation of Adolescents Living With Chronic Fatigue. Health and Quality of Life During the Disease, and How to Remain in School and Spare-time Activities. Testing of a Structured Home-based Rehabilitation Program.

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04177459
Enrollment
3
Registered
2019-11-26
Start date
2019-12-06
Completion date
2020-04-30
Last updated
2020-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue Syndrome, Chronic

Keywords

Adolescent, Fatigue, Rehabilitation, Health Promotion, Health-related Quality of Life, Sense of Coherence, Emotions, Mood, Leisure Activities

Brief summary

Previous studies have shown that health-related quality of life (HRQoL) in adolescents living with chronic fatigue syndrome (CFS/ME) is low if compared with healthy adolescents and adolescents living with other chronic diseases. Effective strategies to improve HRQoL in this group are still lacking. Recently we have observed HRQoL in a group of Norwegian adolescents with CFS/ME (not yet published), which is the background for a new study where we have planned an intervention with health promoting dialogues between patient and nurse, as a strategy to improve HRQoL. In this study we have also opened to include adolescents with other chronic fatigue diagnosis with similar challenges in follow-up as in CFS/ME.

Interventions

BEHAVIORALHealth promoting dialogue

Health promoting dialogues based on the salutogenic theory, focusing on resources within and around the individual, and on coping strategies. Seven individual dialogues for each participant, individually adapted due to the fatigue. The intervention is offered in the participants home or at the local hospital, dependent on the participants fatigue and what is preferred.

OTHERstandard treatment / treatment as usual

Follow-up from primary and secondary health care, and from schools.

Sponsors

Norwegian University of Science and Technology
CollaboratorOTHER
Trondheim Kommune
CollaboratorOTHER
St. Olavs Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* chronic fatigue as main symptom (including but not limited to diagnostic codes ICD-10 G93.3 CFS/ME, F48.0 Neurasthenia, R53 Fatigue) * having undergone an interdisciplinary diagnostic evaluation at The Children's Clinic or at The Fatigue and CFS/ME Outpatient Clinic, St. Olavs hospital during the period 1.8.2019 - 1.4.2020. * being a pupil or wishing to be a pupil.

Exclusion criteria

* not Norwegian speaking * for any reason unable to read and answer a questionnaire * for any reason unable to take part in the health promoting dialogues

Design outcomes

Primary

MeasureTime frameDescription
Health-related quality of life (HRQoL)1 yearassessed by PedsQL Generic Core scale 4.0

Secondary

MeasureTime frameDescription
Fatigue Questionnaire1 yearPedsQL Multidimensional Fatigue Questionnaire
Mood and Feelings Questionnaire1 yearShort Mood and Feelings Questionnaire
Self-reported follow-up, School functioning and participation in Leisure activities1 yearSelf-report form with yes/no answers regarding follow-up from health care personnel, follow-up from school, school attendance and participation in leisure activities.
EQ-5D-5L1 yearEQ-5D-5L is a 5 dimension and 5 level Questionnaire from the Euro Qol Group (supported by the Euro QolGroup Association and Euro Qol Research Foundation). Health states which is defined by EQ-5D-5L-answers, is assigned a score between 0 and 1 by applying preference weights. In Norway it has been common to use preference weights obtained from a sample of the general population in the UK. Norwegian preference weights will be available in near future. EQ-5D is the name of the instrument and is not an acronym. EQ-5D is the correct term to use in print or verbally.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026